Suzanne A.W. Fuqua

21.7k citations

203 papers · 16.6k indexed · 3 hit papers · h-index 69

Molecular Biology top 0.5%
Genetics top 0.05%
Oncology top 0.2%
Cancer Research top 0.2%
Pulmonary and Respiratory Medicine top 1%

Co-authors: William McGuire Gary C. Chamness C. Kent Osborne Gary M. Clark Susan G. Hilsenbeck Steffi Oesterreich D. Craig Allred Matthew H. Herynk
Topics: Estrogen and related hormone effects (103 papers)HER2/EGFR in Cancer Research (38 papers)Retinoids in leukemia and cellular processes (22 papers)
Cited by: Cancer Research Genetics Oncology
Journals: Nucleic Acids Research Journal of Biological Chemistry Journal of Clinical Oncology
Partner nations: United States Italy Canada

In The Last Decade

Suzanne A.W. Fuqua

200 papers receiving 16.2k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Comprehensive Genomic Analysis Identifies Novel Subtypes and Targets of Triple-Negative Breast Cancer

2014 936 citations Matthew D. Burstein, Anna Tsimelzon et al. Clinical Cancer Research profile →
Association of p53 Protein Expression With Tumor Cell Proliferation Rate and Clinical Outcome in Node-Negative Breast Cancer

1993 683 citations D. Craig Allred, Gary M. Clark et al. profile →
Role of the Estrogen Receptor Coactivator AIB1 (SRC-3) and HER-2/neu in Tamoxifen Resistance in Breast Cancer

2003 642 citations C. Kent Osborne, Torsten Hopp et al. profile →

Peers

Countries citing papers authored by Suzanne A.W. Fuqua

Since Specialization

Citations

This map shows the geographic impact of Suzanne A.W. Fuqua's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Suzanne A.W. Fuqua with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Suzanne A.W. Fuqua more than expected).

Fields of papers citing papers by Suzanne A.W. Fuqua

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Suzanne A.W. Fuqua. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Suzanne A.W. Fuqua. The network helps show where Suzanne A.W. Fuqua may publish in the future.

Co-authorship network of co-authors of Suzanne A.W. Fuqua

This figure shows the co-authorship network connecting the top 25 collaborators of Suzanne A.W. Fuqua. A scholar is included among the top collaborators of Suzanne A.W. Fuqua based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Suzanne A.W. Fuqua. Suzanne A.W. Fuqua is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Incongruity between T cell receptor recognition of breast cancer hotspot mutations ESR1 Y537S and D538G following exogenous peptide loading versus endogenous antigen processing 2024 ·Cytotherapy ·Paul Shafer,(unknown),Mae Woods,Jong Min Choi,(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),Bryan M. Burt,Hyun‐Sung Lee,Bing Zhang,Suzanne A.W. Fuqua,Cliona M. Rooney,Ann M. Leen,Valentina Hoyos	1
2	Metabolomic Rewiring Promotes Endocrine Therapy Resistance in Breast Cancer 2023 ·Cancer Research ·(unknown),Jun Hyoung Park,Sandra L. Grimm,Danthasinghe Waduge Badrajee Piyarathna,(unknown),Vasanta Putluri,(unknown),Suzanne A.W. Fuqua,Nagireddy Putluri,Cristian Coarfa,Benny Abraham Kaipparettu	21
3	Phosphatase PTP4A3 Promotes Triple-Negative Breast Cancer Growth and Predicts Poor Patient Survival 2016 ·Cancer Research ·Petra den Hollander,(unknown),Anna Tsimelzon,Jonathan H. Shepherd,Abhijit Mazumdar,Jamal Hill,Suzanne A.W. Fuqua,Jenny C. Chang,C. Kent Osborne,Susan G. Hilsenbeck,Gordon B. Mills,Powel H. Brown	70
4	Androgen receptor promotes tamoxifen agonist activity by activation of EGFR in ERα-positive breast cancer 2015 ·Breast Cancer Research and Treatment ·(unknown),Yassine Rechoum,Guowei Gu,Luca Gelsomino,Amanda Beyer,Lauren Brusco,Kyle R. Covington,Anna Tsimelzon,Suzanne A.W. Fuqua	44
5	Comprehensive Genomic Analysis Identifies Novel Subtypes and Targets of Triple-Negative Breast Cancerbreakdown → 2014 ·Clinical Cancer Research ·Matthew D. Burstein,Anna Tsimelzon,Graham M. Poage,Kyle R. Covington,Alejandro Contreras,Suzanne A.W. Fuqua,Michelle I. Savage,C. Kent Osborne,Susan G. Hilsenbeck,Jenny C. Chang,Gordon B. Mills,Ching C. Lau,Powel H. Brown	936
6	Novel Insights into Breast Cancer Genetic Variance through RNA Sequencing 2013 ·Scientific Reports ·Anélia Horvath,Suresh B. Pakala,Prakriti Mudvari,Sirigiri Divijendra Natha Reddy,Kazufumi Ohshiro,Sandra Casimiro,Ricardo A. Pires,Suzanne A.W. Fuqua,Masakazu Toi,Luís Costa,Sujit S. Nair,Saraswati Sukumar,Rakesh Kumar	54
7	Leptin Mediates Tumor–Stromal Interactions That Promote the Invasive Growth of Breast Cancer Cells 2012 ·Cancer Research ·Ines Barone,Stefania Catalano,Luca Gelsomino,Stefania Marsico,Cinzia Giordano,Salvatore Panza,Daniela Bonofiglio,Gianluca Bossi,Kyle R. Covington,Suzanne A.W. Fuqua,Sebastiano Andò	98
8	Phosphorylated and sumoylation-deficient progesterone receptors drive proliferative gene signatures during breast cancer progression 2012 ·Breast Cancer Research ·Todd P. Knutson,Andrea R. Daniel,Danhua Fan,Kevin A.T. Silverstein,Kyle R. Covington,Suzanne A.W. Fuqua,Carol A. Lange	85
9	Leptin increases HER2 protein levels through a STAT3‐mediated up‐regulation of Hsp90 in breast cancer cells 2012 ·Molecular Oncology ·Cinzia Giordano,Donatella Vizza,Salvatore Panza,Ines Barone,Daniela Bonofiglio,Marilena Lanzino,Diego Sisci,Francesca De Amicis,Suzanne A.W. Fuqua,Stefania Catalano,Sebastiano Andò	74
10	Dicer-Mediated Upregulation of BCRP Confers Tamoxifen Resistance in Human Breast Cancer Cells 2011 ·Clinical Cancer Research ·Jennifer Selever,Guowei Gu,Michael T. Lewis,Amanda Beyer,Matthew H. Herynk,Kyle R. Covington,Anna Tsimelzon,Gabriela Dontu,Patrick Provost,Attilio Di Pietro,Ahcène Boumendjel,Kathy S. Albain,Lucio Miele,Heidi L. Weiss,Ines Barone,Sebastiano Andò,Suzanne A.W. Fuqua	45
11	Resveratrol, through NF‐Y/p53/Sin3/HDAC1 complex phosphorylation, inhibits estrogen receptor α gene expression via p38 ^MAPK /CK2 signaling in human breast cancer cells 2011 ·The FASEB Journal ·Francesca De Amicis,Francesca Giordano,Adele Vivacqua,Michele Pellegrino,Maria Luisa Panno,Donatella Tramontano,Suzanne A.W. Fuqua,Sebastiano Andò	62
12	Accelerated mammary maturation and differentiation, and delayed MMTVneu-induced tumorigenesis of K303R mutant ERα transgenic mice 2009 ·Oncogene ·Matthew H. Herynk,Michael T. Lewis,Torsten Hopp,Daniel Medina,(unknown),Yukun Cui,Amanda Beyer,Suzanne A.W. Fuqua	4
13	Production and Characterization of an Estrogen Receptor β Subtype-Specific Mouse Monoclonal Antibody 2000 ·Hybridoma ·Jui‐Lan Su,David D. McKee,Byron Ellis,Sue H. Kadwell,G. Bruce Wisely,Linda B. Moore,(unknown),Thomas A. Kost,Suzanne A.W. Fuqua,John T. Moore	7
14	The role of the estrogen receptor in tumor progression 1996 ·The Journal of Steroid Biochemistry and Molecular Biology ·Pierre Lemieux,Suzanne A.W. Fuqua	49
15	The SH2 domain protein GRB-7 is co-amplified, overexpressed and in a tight complex with HER2 in breast cancer. 1994 ·The EMBO Journal ·D. L. Stein,Jian Wu,Suzanne A.W. Fuqua,(unknown),Vijay Yajnik,Peter D’Eustachio,John J. Moskow,Arthur M. Buchberg,C. Kent Osborne,Ben Margolis	206
16	Cathepsin D by western blotting and immunohistochemistry: failure to confirm correlations with prognosis in node-negative breast cancer. 1994 ·Journal of Clinical Oncology ·Peter M. Ravdin,Amol Tandon,D. Craig Allred,Gary M. Clark,Suzanne A.W. Fuqua,(unknown),Gary C. Chamness,C. Kent Osborne	47
17	Heat shock proteins and drug resistance 1994 ·Breast Cancer Research and Treatment ·Suzanne A.W. Fuqua,Steffi Oesterreich,Susan G. Hilsenbeck,Daniel D. Von Hoff,John R. Eckardt,C. Kent Osborne	98
18	Glutathione Transferase GSTπ In Breast Tumors Evaluated By Three Techniques 1993 ·Disease Markers ·Rafael Molina,Steffi Oesterreich,Jian‐Liang Zhou,Atul K. Tandon,Gary M. Clark,D. Craig Allred,Alan J. Townsend,(unknown),Kenneth H. Cowan,William McGuire,Suzanne A.W. Fuqua	12
19	HER-2/neu amplification predicts poor survival in node-positive breast cancer. 1990 ·PubMed ·Åke Borg,Amol Tandon,Helgi Sigurðsson,Gary M. Clark,Mårten Fernö,Suzanne A.W. Fuqua,D. Killander,(unknown)	393
20	Chromosomal assignments of human 27-kDa heat shock protein gene family 1989 ·Somatic Cell and Molecular Genetics ·Sean E. McGuire,Suzanne A.W. Fuqua,Susan L. Naylor,(unknown),William McGuire	19

About Suzanne A.W. Fuqua

Suzanne A.W. Fuqua is a scholar working on Genetics, Oncology and Cancer Research, having authored 203 papers that have together received 16.6k indexed citations. Recurring topics across this work include Estrogen and related hormone effects (103 papers), HER2/EGFR in Cancer Research (38 papers) and Retinoids in leukemia and cellular processes (22 papers). The work is most often cited by research in Cancer Research (4.0k citations), Genetics (6.6k citations) and Oncology (6.4k citations). Suzanne A.W. Fuqua has collaborated with scholars based in United States, Italy and Canada. Frequent co-authors include William McGuire, Gary C. Chamness, C. Kent Osborne, Gary M. Clark, Susan G. Hilsenbeck, Steffi Oesterreich, D. Craig Allred, D. Craig Allred, C. Kent Osborne and Matthew H. Herynk. Their work appears in journals such as Nucleic Acids Research, Journal of Biological Chemistry and Journal of Clinical Oncology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact